Security key
36151G402
INTELLIGENT BIO SOLUTIONS INC. - Class A Common Stock, $0.001 par value (INBS)
CUSIP: 36151G402
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Class A Common Stock, $0.001 par value
- Total 13F shares
- 3,038
- Total 13F value
- $8,445
- Share change
- -223,188
- SEC-reported price per share
- $2.76
- Number of holders
- 2
- Value change
- -$642,459
- Number of buys
- 2
- Number of sells
- 3
- Shares outstanding
- 9,452,553
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
2
Top holders
2
INBS full security history
Ownership snapshot
Full 13F holder table
INTELLIGENT BIO SOLUTIONS INC. SEC filings
INTELLIGENT BIO SOLUTIONS INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of INBS - INTELLIGENT BIO SOLUTIONS INC. - Class A Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Life Science Biosensor Di...
Disclosed value leader
Life Science Biosensor Di...
Comparable rows
0/11
Latest evidence
12 May 2023
3/4/5
13F
Highest disclosed value: $2,001,337
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
Life Science Biosensor Diagnostics Pty Ltd has the largest disclosed position value at $2M.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Life Science Biosensor Diagnostics Pty Ltd's linked filing trail.
Disclosed position value
Top 5
Life Science Biosensor Diagnostic...
$2M
Ma-Ran Foundation
$394.5K
Gary W. Rollins Foundation
$352.4K
SABBY MANAGEMENT, LLC
$367.3K
Walleye Capital LLC
$273.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Life Science Biosensor Diagnostics Pty Ltd |
3/4/5
Former 10% owner
|
—
denominator unverified
|
$2,001,337
1,081,804 shares
|
— | 17 Feb 2022 |
| Ma-Ran Foundation |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$394,540
213,265 shares
|
— | 12 May 2023 |
| Gary W. Rollins Foundation |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$352,405
190,489 shares
|
— | 12 May 2023 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$367,285
126,650 shares
|
— | 31 Mar 2023 |
| Walleye Capital LLC |
13F
Company
|
—
denominator unverified
|
$273,794
96,068 shares
|
— | 31 Mar 2023 |
| George Margelis |
3/4/5
Director
|
—
denominator unverified
|
$27,750
15,000 shares
|
— | 10 Oct 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
3,038
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
5
Q2 2023 holders
2
Holder diff
-3
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|